STOCK TITAN

Sachem Capital Financials

SACH
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Sachem Capital (SACH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SACH FY2025

This is a balance-sheet-driven business where funding costs, cash conversion, and payout coverage matter more than reported revenue.

In FY2025, net income and cash flow diverged: net income was $6.3M but operating cash flow was only $2.7M. That reversal from FY2024—when a -$39.6M loss still came with $12.9M of operating cash flow—shows earnings are moving with balance-sheet timing more than cash realization, which makes headline profitability a weaker guide to cash available for payouts.

Funding cost mattered more than overhead in the recovery: interest expense fell to $11.7M in FY2025 from $20.5M in FY2024. By contrast, SG&A barely moved, so the return to profit looks tied more to the liability side of the balance sheet than to broad expense cutting; this behaves more like a financing structure than a sales engine.

Leverage rose even while the company shrank: debt-to-equity reached 1.6x in FY2025 versus 1.3x in FY2024 because equity eroded faster than liabilities. Positive investing cash flow of $29.4M and negative financing cash flow of -$39.2M indicate assets were being run off to support deleveraging and dividends, not balance-sheet expansion, which helps explain the smaller asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 12 / 100
Financial Profile 12/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Sachem Capital's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
69

Sachem Capital carries a low D/E ratio of 1.63, meaning only $1.63 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.

Returns
4

Sachem Capital generates a 3.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 4/100. This is up from -21.8% the prior year.

Piotroski F-Score Neutral
4/9

Sachem Capital passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.42x

For every $1 of reported earnings, Sachem Capital generates $0.42 in operating cash flow ($2.7M OCF vs $6.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
$6.3M
YoY+115.9%
5Y CAGR-6.8%

Sachem Capital reported $6.3M in net income in fiscal year 2025. This represents an increase of 115.9% from the prior year.

EPS (Diluted)
$0.04
YoY+104.3%
5Y CAGR-37.2%

Sachem Capital earned $0.04 per diluted share (EPS) in fiscal year 2025. This represents an increase of 104.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$10.9M
YoY-39.5%
5Y CAGR-10.9%

Sachem Capital held $10.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
48M
YoY+1.5%
5Y CAGR+16.6%

Sachem Capital had 48M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
3.6%
YoY+25.4pp
5Y CAGR-7.5pp

Sachem Capital's ROE was 3.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 25.4 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$0
YoY-100.0%

Sachem Capital spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures
N/A

SACH Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A $12.0M+11.4% $10.8M-5.8% $11.4M+6.3% $10.8M-27.2% $14.8M-2.4% $15.1M-9.9% $16.8M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A $1.7M+28.8% $1.3M-3.8% $1.4M-33.7% $2.0M-11.2% $2.3M+82.9% $1.3M+1.5% $1.2M
Operating Income N/A -$367K-134.4% $1.1M+3.6% $1.0M+107.3% -$14.1M-192.6% -$4.8M-54.7% -$3.1M-172.9% $4.3M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A $0 $0 $0 $0 $0 $0-100.0% $200K
Net Income N/A $997K-47.2% $1.9M+108.7% $904K+102.5% -$36.1M-615.4% -$5.1M-65.3% -$3.1M-165.4% $4.7M
EPS (Diluted) N/A $0.00-100.0% $0.02 $0.00 N/A $-0.13-44.4% $-0.09-212.5% $0.08

SACH Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $460.0M-5.0% $484.4M-3.5% $501.8M+2.1% $491.4M-0.1% $492.0M-11.4% $555.5M-5.3% $586.3M-6.4% $626.5M
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $10.9M-2.2% $11.2M-50.3% $22.5M-7.9% $24.4M+35.1% $18.1M+207.2% $5.9M-44.4% $10.6M-42.6% $18.4M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $391K0.0% $391K0.0% $391K0.0% $391K0.0% $391K0.0% $391K0.0% $391K0.0% $391K
Total Liabilities $285.1M-7.7% $308.8M-4.7% $323.9M+3.8% $312.1M+0.6% $310.3M-7.3% $334.9M-6.0% $356.2M-8.5% $389.1M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A $230.2M0.0% $230.2M-13.0% $264.7M0.0% $264.7M-8.2% $288.4M
Total Equity $174.9M-0.4% $175.6M-1.3% $177.9M-0.8% $179.3M-1.3% $181.7M-17.7% $220.6M-4.2% $230.2M-3.1% $237.4M
Retained Earnings N/A N/A N/A N/A N/A -$35.8M-38.5% -$25.8M-56.7% -$16.5M

SACH Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$3.0M-160.1% $4.9M+884.4% $501K+162.3% $191K+130.8% -$620K-126.6% $2.3M-66.5% $7.0M+65.1% $4.2M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $27.8M+553.7% $4.2M+150.5% -$8.4M-246.3% $5.7M-83.9% $35.6M+113.1% $16.7M-27.9% $23.2M+437.5% $4.3M
Financing Cash Flow -$25.0M-22.3% -$20.5M-443.4% $6.0M+1354.6% $410K+101.8% -$22.8M+3.8% -$23.8M+37.5% -$38.0M-1297.0% -$2.7M
Dividends Paid $2.4M0.0% $2.4M+0.9% $2.4M+0.1% $2.4M+0.6% $2.3M-38.1% $3.8M-27.3% $5.2M+1.5% $5.1M
Share Buybacks $0 N/A N/A N/A $115K N/A N/A N/A

SACH Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A -3.1%-13.0pp 9.9%+0.9pp 9.0%+140.1pp -131.1%-98.4pp -32.6%-12.0pp -20.6%-46.0pp 25.4%
Net Margin N/A 8.3%-9.2pp 17.5%+9.6pp 7.9%+343.5pp -335.6%-301.5pp -34.2%-14.0pp -20.2%-48.0pp 27.8%
Return on Equity N/A 0.6%-0.5pp 1.1%+0.6pp 0.5%+20.4pp -19.9%-17.6pp -2.3%-1.0pp -1.3%-3.3pp 2.0%
Return on Assets N/A 0.2%-0.2pp 0.4%+0.2pp 0.2%+7.5pp -7.3%-6.4pp -0.9%-0.4pp -0.5%-1.3pp 0.8%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 1.63-0.1 1.76-0.1 1.82+0.5 1.28+0.0 1.27+0.1 1.20+0.0 1.15-0.1 1.21
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Yes, Sachem Capital (SACH) reported a net income of $6.3M in fiscal year 2025.

Sachem Capital (SACH) reported diluted earnings per share of $0.04 for fiscal year 2025. This represents a 104.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sachem Capital (SACH) has a return on equity of 3.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Sachem Capital (SACH) generated $2.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Sachem Capital (SACH) had $460.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Sachem Capital (SACH) had 48M shares outstanding as of fiscal year 2025.

Sachem Capital (SACH) had a debt-to-equity ratio of 1.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sachem Capital (SACH) had a return on assets of 1.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Sachem Capital (SACH) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sachem Capital (SACH) has an earnings quality ratio of 0.42x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sachem Capital (SACH) scores 12 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top